Background: Non-receptor protein-tyrosine kinases often contain at least one Src homology 2 (SH2) domain, a protein module that binds with high affinity to tyrosinephosphorylated peptides. Because SH2 domains would be predicted to bind with high affinity to proteins phosphorylated by the kinase, but not to the unphosphorylated substrate, their presence in tyrosine kinases has been puzzling. An important role for the SH2 domain of the Abl tyrosine kinase was suggested by work showing that Abl requires an intact SH2 domain in order to malignantly transform cells, and that replacement of the Abl SH2 domain with heterologous SH2 domains alters the spectrum of proteins phosphorylated detectably by Abl in vivo. Results: We have used purified wild-type and mutant Abl kinases to examine the roles of the Abl's SH2 and catalytic domains in phosphorylation of p130CAS, a model substrate that has multiple potential phosphorylation sites. We find that an SH2 domain is required for efficient hyperphosphorylation of p130 in vitro. We use chimeric mutants with heterologous SH2 domains to demonstrate that the SH2 domain of the oncogenically transforming adaptor protein Crk, which is the SH2 domain predicted to bind with highest affinity (of those tested) to potential phosphorylation sites in p130, is best able to facilitate hyperphosphorylation. This is the case whether the catalytic domain of the kinase is derived from Abl or from its distant relative, Src. These studies also reveal a role for binding of Crk to Abl in mediating phosphorylation by the kinase. Using purified proteins, we demonstrate that association with Crk strikingly enhances the ability of Abl to hyperphosphorylate pl30. There is an excellent correlation between the ability of mutant Crk proteins to promote hyperphosphorylation of p130 by Abl and their ability to transform rodent fibroblasts. Conclusion: Our data suggest that, ultimately, the substrate specificity of a non-receptor tyrosine kinase is dependent on the binding specificity of its associated SH2 domain. The SH2 domain binds tightly to a subset of proteins phosphorylated by the catalytic domain, leading to processive phosphorylation of those proteins. Substrate specificity can be broadened by an association between the kinase and proteins, such as Crk, that contain additional SH2 domains; this may play a role in malignant transformation by Crk.
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Background
Protein-tyrosine kinases play a central role in the signal transduction machinery of complex eukaryotes. Their importance in regulating cell proliferation is highlighted by observations that the receptors for many peptide mitogens have intrinsic tyrosine kinase activity, and that disregulated tyrosine kinases can often induce malignant transformation [1] . There are two broad classes of tyrosine kinases, the receptor and non-receptor types. The receptor class contain extracellular ligand-binding and intracellular catalytic domains, and they are activated by ligand binding. The non-receptor kinases are entirely intracellular, and their activity is presumed to be regulated by association with other proteins.
The substrates phosphorylated by tyrosine kinases have been the subject of intense research for many years, but the identification of physiologically relevant substrates has proven surprisingly difficult. A major reason for this is that tyrosine-phosphorylated proteins are generally present in cells at very low levels. Indeed, in cells expressing a transforming tyrosine kinase, or in cells stimulated with the ligand for a tyrosine kinase growth factor receptor, the most prominent tyrosine-phosphorylated protein is often the autophosphorylated kinase itself. This suggests that the tyrosine kinases do not amplify signals by phosphorylating many molecules in a short time, but might instead signal by selectively phosphorylating only a few proteins.
An important clue to the mechanism of signaling by tyrosine kinases emerged from studies of the Src homology 2 (SH2) domain, a small protein module that is found in many signaling proteins [2, 3] . SH2 domains bind with high affinity to tyrosine-phosphorylated peptide sequences. Different SH2 domains bind with highest affinity to different specific peptide sequences, depending largely on the three amino acids carboxy-terminal to the phosphorylated tyrosine [4, 5] . It has become apparent that one critical feature of signaling by activated receptor tyrosine kinases is the binding of SH2-containing proteins from the cytoplasm to tyrosine-phosphorylated sites on the receptor [6] . Binding to the receptor facilitates phosphorylation of these cytoplasmic proteins and relocalizes them so they are in proximity to membranebound substrates.
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Unlike the receptor class, non-receptor tyrosine kinases do not contain ligand-binding domains, but instead often contain at least one SH2 domain located amino-terminal to the catalytic domain. The SH2 region has long been known to have a modulatory function for the non-receptor tyrosine kinases, but the mechanism of this modulation is still not entirely clear. In the case of the well-studied Src kinase, the SH2 domain has both a positive and a negative role: it helps to hold the non-transforming c-src gene product in an inactive conformation through interactions with a carboxy-terminal regulatory phosphotyrosine within the same Src molecule [7, 8] , but SH2 mutations generally decrease the transforming activity of 'activated' src genes [9] [10] [11] [12] , suggesting that the domain has a positive role in phosphorylation by the kinase.
The situation is somewhat different in the case of the Abl non-receptor tyrosine kinase. Abl was originally isolated as the product of the transforming gene in Abelson murine leukemia virus, and the abl gene was subsequently shown to be fused to sequences from bcr, another chromosomal locus, in virtually all cases of human chronic myelogenous leukemia [13] [14] [15] . We have previously shown that an intact SH2 domain is absolutely required for transformation of fibroblasts by an activated abl gene, whereas no negative role for the SH2 domain is apparent [16, 17] . We have also shown that lack of the Abl SH2 domain can be complemented by its replacement with SH2 domains from other proteins, and that the spectrum of tyrosinephosphorylated proteins in cells expressing these variant Abl genes varies with the different SH2 domains [17] . We inferred from these results that an SH2 domain is required in order to bind to a subset of proteins phosphorylated by the catalytic domain, thereby allowing repeated 'processive' phosphorylation of multiple sites on bound proteins, or else protecting those substrates from dephosphorylation by tyrosine phosphatases. In the absence of a suitable natural substrate for Abl, however, it was impossible to test this model in vitro with purified proteins.
Two groups recently reported [18, 19] that Abl can bind to a class of proteins called SH2-SH3 adaptors, which consist entirely of SH2 domains together with another small protein-binding module, the SH3 domain. The adaptors are thought to function in the coupling of signals initiated by tyrosine phosphorylation (via SH2 binding) to downstream effectors (via SH3 binding; reviewed in [2, 3, 20] ). The binding of one of these adaptors, Crk, was of particular interest for several reasons. Crk was originally isolated as the product of an oncogene from avian sarcoma viruses [21, 22] , and both the viral forms and the cellular homolog have the ability to transform cells malignantly when overexpressed [22] [23] [24] . Crk-transformed cells have an increase in the phosphotyrosine content of several proteins, and the Crk protein is associated with these phosphoproteins and with tyrosine kinase activity in lysates [22, 25] . Taken together, these results suggested that endogenous Abl kinase might associate with the Crk adaptor protein in transformed cells and might be responsible for the tyrosine phosphorylation observedand hence for transformation. It was not known, however, what effect Crk binding might have on Abl kinase activity, or how this could be responsible for the apparent kinase activation seen in Crk-transformed cells.
In this work, we use the major tyrosine-phosphorylated protein in Crk-transformed cells, pl30CAS (called CAS for 'Crk-associated substrate') [26] , as a model substrate with which to examine the roles of the SH2 and catalytic domains in the substrate specificity of the Abl kinase. We find that an SH2 domain is required for efficient hyperphosphorylation of p130. Furthermore, the efficacy of the SH2 domain in promoting hyperphosphorylation is correlated with its predicted ability to bind to tyrosinephosphorylated sites on the substrate; the most effective of the SH2 domains tested is that from Crk. Finally, we show that binding of Crk to Abl serves to stimulate the ability of Abl to phosphorylate p 1 30 , consistent with a model in which Crk transforms cells at least in part by altering the substrate specificity of Abl and inducing the hyperphosphorylation of substrates such as p 1 30 .
Results
An SH2 domain promotes p130 hyperphosphorylatiQn by Abl
We chose to examine the contribution of the SH2 and catalytic domains to the kinase activity of the Abl nonreceptor tyrosine kinase using p130 as a model substrate; p130 is the major tyrosine-phosphorylated protein in fibroblasts that are transformed by the v-crk oncogene, and phosphorylated p130 binds with high affinity to the SH2 domain of Crk [26] . We chose this protein as a substrate for several reasons. First, p130 is a good candidate for a bona fide substrate of c-Abl in vivo, because it is phosphorylated in cells transformed by Crk, where Abl and Crk have been shown to be associated with each other [18, 19, 26] . The p130 protein is also phosphorylated by, and associated with, the Src kinase in Src-transformed cells, suggesting that it might be a good substrate for a number of different tyrosine kinases [26] . The p130 protein has numerous potential phosphorylation sites, including nine sites with the sequence Tyr-Asp-X-Pro, where X is threonine or valine. These sites closely match the predicted high-affinity binding site for the Crk SH2 domain [4] . It is important that the model substrate has numerous phosphorylation sites, in order to test whether the SH2 domain can facilitate processive phosphorylation of multiple sites on one substrate.
For our kinase assays, we used purified Abl proteins produced by infection of insect cells with recombinant baculovirus expressing mutant and wild-type forms of Abl as fusion proteins with glutathione S-transferase (GST). Fusion proteins were purified by affinity chromatography on glutathione-agarose and cleaved from GST using thrombin. We also produced p130 as a GST fusion protein, in this case by transient transfection of 293 cells, and the purified protein was used without cleaving off the GST. The ability to phosphorylate (Fig. lb) . Retarded mobility on SDS gels is commonly observed when proteins are phosphorylated, and we assume that the slower-migrating forms are multiply phosphorylated for several reasons. In previously published work [26] and in our experiments, the most slowly migrating p13 0 species react more intensely with anti-phosphotyrosine antibodies than with antibodies against p130 (or GST, in the case of GST-pl30), relative to the more rapidly migrating forms. Furthermore, when the stoichiometry of phosphorylation was calculated using labeled ATP, more than 1 mole of phosphate per p130 molecule was detected in the slower-migrating forms (data not shown). The complex 'ladder' of intermediate apparent molecular weights also suggests multiple phosphorylation sites, but makes precise determination of the stoichiometry of phosphorylation of any component band difficult. Finally, in pulse-chase experiments using labeled ATP, radioactivity could be chased from the more rapidly migrating form to the more slowly migrating forms after Fig. 2 . Structure of chimeric Abl kinases, drawn to scale. Positions of the SH3, SH2 and catalytic domains are indicated, as is the proline-rich site in the carboxy-terminus (Pro), which binds to the Crk SH3 domain. For mutants containing heterologous SH2 domains, the origin of the SH2 domain is indicated (PIK denotes PI 3-kinase p 85 subunit). The name of each construct is shown on the left of the figure. GST is fused to the amino terminus of all kinases used for the experiment shown in Fig. 3 , and is not shown in this figure.
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incubation with an excess of unlabeled ATP, demonstrating that the slower-migrating forms are more highly phosphorylated (data not shown).
The three Abl variants had equal activity toward monovalent substrates, such as angiotensin, or high concentrations of non-specific co-polymer substrate poly(Glu-Tyr), when tested under similar kinase conditions ( [17] and data not shown). The mutant lacking the SH2 domain is therefore not impaired in kinase activity in general, but it is impaired in the ability to hyperphosphorylate low concentrations of the multivalent substrate p 1 30. These data are entirely consistent with a model in which the SH2 domain does not affect kinase activity directly, but instead has an indirect effect in promoting processive phosphorylation by binding to phosphorylated product. Because we used purified proteins, the tyrosine phosphatase activity in the reactions is likely to be low relative to the kinase activity, so the results are inconsistent with a model in which SH2 domains enhance phosphorylation by merely protecting the product from dephosphorylation. Similar results are obtained if the tyrosine phosphatase inhibitor sodium orthovanadate is present in the reaction mix (data not shown). of whether they contained the Abl or the Src catalytic domain. For each series, the mutant with the PI 3-kinase SH2 domain was the poorest at p130 hyperphosphorylation, whereas the mutants with the Abl, Src and GAP SH2 domains were intermediate in activity. The mutant containing only the Abl SH2 and catalytic domains was surprisingly weak in p130 hyperphosphorylating activity compared with other mutants in these conditions, but as shown in Figure 1 and on longer exposures of this gel, the Abl SH2 increased p130 hyperphosphorylation relative to that obtained with the mutant lacking an SH2 domain.
The mutant kinases were normalized for their ability to phosphorylate the nonspecific poly(Glu-Tyr) co-polymer
The Crk SH2 domain specifically directs hyperphosphorylation of p130 We next examined the relative contributions of the SH2 and catalytic domains to substrate specificity, as assayed by hyperphosphorylation of p130. For these experiments, we used the panel of mutant Abl kinases shown in Figure 2 . The mutants ASH3, GG, GS, GP and GC are variants of Abl in which the SH2 domain is derived from Abl, GAP (the Ras GTPase activator protein; aminoterminal SH2 domain), Src, phosphatidylinositol (PI) 3-kinase p85 subunit (carboxy-terminal SH2 domain) or Crk, respectively. To test the effect of a catalytic domain other than that of Abl, the 'GSC' series of mutants was constructed containing the same series of SH2 domains but with the Abl catalytic domain replaced with that of the Src tyrosine kinase. This collection of mutant proteins allows the controlled analysis of contributions by the SH2 and catalytic domains, because all mutants are in the same 'framework' provided by the amino-and carboxy-terminal sequences derived from Abl. All of these kinases have the ability to transform NIH 3T3 cells to some extent [17] , demonstrating that the modular SH2 and catalytic domains can function in the context of the Abl backbone (the SH3 domain is deleted in all these mutants; this is required in the case of Abl in order for the kinase to have transforming activity, but it has no apparent effect on kinase activity in vitro).
The mutants shown in Figure 2 , including a mutant that contains the SH3 domain but lacks any SH2 domain (ASH2), were expressed as GST fusion proteins, purified by affinity chromatography, eluted and assayed for their ability to phosphorylate GST-p130. As shown in Figure 3a , the kinases containing the Crk SH2 domain were best able to hyperphosphorylate p130, irrespective In (c) no exogenous substrate was included. Products of kinase assays in vitro were separated by SDS-PAGE and visualized by autoradiography. The arrow in (c) indicates the position of autophosphorylated GST-Abl kinase. The positions and apparent molecular weights (in kD) of markers are indicated on the left. RESEARCH PAPER 299 substrate (Fig. 3b) , so again there was no global effect of SH2 domain substitution on kinase activity. The mutants that had Src catalytic domains were much more active than those with the Abl catalytic domain (approximately 15-20-fold higher specific activity) in phosphorylating poly(Glu-Tyr), whereas there was little difference in their relative ability to phosphorylate p130 (for example, compare lanes 7 and 12, Figs 3a and 3b) . This is consistent with the predicted specificity of the Src and Abl catalytic domains, as determined recently by Cantley and colleagues [27] . They showed that Abl preferentially phosphorylates sites containing small hydrophobic residues, whereas Src has a strong preference for acidic residues both amino-and carboxy-terminal to the phosphorylated tyrosine. The random glutamic acid-tyrosine co-polymer substrate is highly acidic and more nearly conforms to the preferences of the Src catalytic domain. Figure 3c shows the autophosphorylating activity of the various mutant kinases in the same conditions as those used in Figure 3a (except for the lack of p130 substrate), demonstrating that autophosphorylation occurred at roughly the same level for all the mutants and was insignificant compared to phosphorylation of exogenous p130 substrate. Similar results were obtained if Abl was first cleaved from GST using thrombin (data not shown).
The results described above are again consistent with a model in which processive phosphorylation depends on binding of an early phosphorylated tyrosine to the SH2 domain. The Crk SH2 domain is predicted to have a very high affinity for many of the potential tyrosine phosphorylation sites in p130. Cantley's group [4, 5] has shown that aspartic acid in the +1 position and (especially) proline in the +3 position are strongly selected by the Crk SH2 domain; nine of the potential p130 phosphorylation sites contain these residues. The Src and Abl SH2 domains are predicted to have moderately high affinity for several of the potential phosphorylation sites (although the Abl SH2 domain also selects proline at the +3 position, the selection is not as strong as for the Crk SH2 domain and there is no selection for aspartate at +1). The GAP SH2 domain's binding preference has not yet been published, but by sequence comparison it is predicted to be in the same general class as Crk, Src and Abl. The SH2 domain that is predicted to bind most poorly is that from PI 3-kinase, which is highly selective for a hydrophobic residue at +1 and especially for methionine at +3. There are no tyrosines in p130 that conform to this consensus.
The origin of the catalytic domain has little influence on the hyperphosphorylation of p 1 30; mutants with catalytic domains from Src or Abl are roughly equal in their ability to phosphorylate p130. There certainly is specificity in catalytic domains, as shown by Cantley's group [27] and by the preferential phosphorylation of poly(Glu-Tyr) by the kinases containing the Src catalytic domain; but in this study, with moderately low concentrations of a physiological substrate, the SH2 domain is critical in determining whether or not processive phosphorylation will occur.
Effect of Crk binding to Abl kinase
The results outlined above demonstrate that within a single molecule (in cis), the Crk SH2 domain is much more effective than that of Abl in promoting the hyperphosphorylation of p 1 30. We were therefore interested in whether binding of Crk protein to Abl in trans could give the same effect. Because Crk binds via its SH3 domain to Abl [18, 19] , its SH2 domain is free to bind to proteins phosphorylated by the catalytic domain, and might therefore be expected to facilitate processive phosphorylation.
Crk is found in two forms generated by alternate splicing, Crk-1 and Crk-2, which have one or two SH3 domains, respectively [24] . In normal cells, the Crk-2 form predominates [23, 24, 28] . High levels of overexpression of the Crk-1 form can transform rodent fibroblasts, whereas the Crk-2 form is less active in this assay [23, 24] . We find that the Crk-2 form consistently causes morphological alteration and increased saturation density when overexpressed in NIH 3T3 cells, but the morphology of cells is less dramatically altered than in cells expressing the Crk-1 form (our unpublished observations). Mutagenesis studies have shown that both an intact SH2 domain and an amino-terminal SH3 domain are required for transformation of chicken embryo fibroblasts by v-crk [29] , for coupling of growth-factor receptors to Ras by microinjected Crk-1 and Crk-2 in PC12 cells [30] , and for morphological alteration of NIH 3T3 cells by Crk-1 and Crk-2 (BJ.M., unpublished observations).
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Feller and Hanafusa [18] have proposed that tyrosine phosphorylation of Crk-2 is responsible for its weaker transforming activity, because intramolecular SH2-phosphotyrosine interactions would make the SH2 domain unavailable for interaction with other proteins in trans. We mutated the major site of tyrosine phosphorylation of Crk-2 (tyrosine 222 in the chicken c-Crk used here) to phenylalanine, to assess the effect on p130 phosphorylation. As seen in Figure 4 , unlike wild-type Crk-2, the Crk-2F 2 22 mutant is not efficiently tyrosine phosphorylated, and it is now as active as Crk-1 as a p130 processivity factor (Fig. 4, lane 5; compare with lanes 2 and 4) . Consistent with this, when expressed in 3T3 cells by retroviral infection, the Crk-2F 2 2 2 mutant induces a transformed morphology similar to that of cells expressing Crk-1 and unlike the more subtle alteration induced by Crk-2 (our unpublished observations).
For kinase assays in vitro, purified Abl kinase was incubated with an excess of bacterially produced GST-Crk-1 or GST-Crk-2 fusion protein, and then GST-pl130 substrate was added in a reaction mixture containing Mg 2 + and labeled ATP. As shown in Figure 4 , under these conditions Abl cannot hyperphosphorylate p130 in the absence of added Crk protein (lane 1). However, if either Crk-1 or Crk-2 protein is prebound to Abl, p130 is efficiently hyperphosphorylated, as indicated by the appearance of a slower-migrating p130 band (Fig. 4, lanes 2 and 4) . This demonstrates that the Crk SH2 domain in trans can alter the activity of Abl towards p130. In contrast to its effect on p130 hyperphosphorylation, Crk binding had no effect on the activity of Abl toward the monovalent substrate, angiotensin ( Table 1 ).
The ability of Crk peptides to facilitate processive phosphorylation correlated with their ability to induce transformation. The Crk-1 form is more active than the Crk-2 form in stimulating p130 hyperphosphorylation (Fig. 4, compare lanes 2 and 4) , correlating with its stronger transforming activity. As expected, if the SH3 domain of Crk-1 is mutated by a single amino-acid change that eliminates binding to Abl, the mutant Crk protein is unable to act as a processivity factor (Fig. 4,  lane 3) . Furthermore, a Crk-2 protein in which the SH2 domain carries a mutation in its phosphotyrosine-binding site is much weaker in facilitating processive phosphorylation (Fig. 4, lane 6) .
From the results shown in Figure 4 , it is apparent that Crk-2 protein is highly phosphorylated by Abl, whereas Crk-1 is phosphorylated only at a low level (Fig. 4, lanes  2 and 4) . This is also the case in vivo, where Crk-2 (but not Crk-1) is tyrosine-phosphorylated when overexpressed ( [18] and BJ.M., unpublished observations).
We next examined the concentration of Crk-1 protein necessary to induce hyperphosphorylation of p130 by Abl. We tested both c-Abl and an SH3-deleted form of Abl, which unlike c-Abl is highly transforming when expressed in 3T3 cells. The reason we wished to compare the two forms is that it is possible that the SH3 domain of Abl might itself compete with the Crk SH3 domain for binding to the proline-rich site in the Abl carboxyl terminus. If this were the case, then higher 'concentrations of Crk would be required to bind to the wild-type c-Abl than to the SH3-deleted form. As shown in Figure  5 , similar concentrations of Crk protein are required to promote hyperphosphorylation of p130 by c-Abl (left) Fig. 5 . Concentration-dependence of the ability of GST-Crk to facilitate hyperphosphorylation of p130 by c-Abl and by an Abl SH3 domain deletion mutant. GST-Crk-1 protein was preincubated with purified, dephosphorylated c-Abl kinase (left) or the ASH3 deletion mutant kinase (right). Kinase assays were performed in vitro using GST-p130 as substrate, and or the transforming, SH3-deleted form of Abl (right), suggesting that the Abl SH3 domain does not block Crk binding. For both forms of Abl, half-maximal stimulation of hyperphosphorylation is seen at concentrations of Crk protein of between 10 -6 and 10 -7 M, suggesting that there is a high-affinity interaction between Crk and Abl that could occur under physiological conditions.
Discussion
The work described here provides a mechanistic explanation for the role of the SH2 domain in non-receptor tyrosine kinases. Although it has long been recognized that the SH2 domain plays a positive role in the transforming activity of activated alleles of the src and abl kinase-encoding genes, and that it can affect the phosphorylation of particular substrates in vivo, the mechanism was obscure. We have shown here that an SH2 domain is required for the efficient processive phosphorylation of a multivalent substrate, and that the efficacy of an SH2 domain correlates with its predicted ability to bind tightly to phosphorylated sites on the substrate protein. We have also shown that the Crk adaptor protein can bind to Abl and donate its SH2 domain in trans, serving as a processivity factor for the kinase.
Our results suggest that processive phosphorylation is triggered by binding of the SH2 domain of the kinase (or of an associated protein such as Crk) to a tyrosinephosphorylated site on a substrate protein. Thus, both the catalytic and SH2 domains contribute to determining which proteins become highly phosphorylated. The SH2 domain cannot bind to a substrate unless it is first phosphorylated by the catalytic domain, but processive phosphorylation will not occur unless the SH2 domain can bind tightly to the phosphorylated site. Once bound, the extremely high local concentration of the bound substrate drives phosphorylation of all sites that are sterically accessible to the catalytic domain. It is interesting that Cantley's group [27] has found that the substrate specificity of the catalytic domains of various non-receptor tyrosine kinases correlates quite well with the specificity of their associated SH2 domains, suggesting that the two domains co-evolved in order to achieve processive phosphorylation of substrates.
Although few biologically relevant substrates are known for the non-receptor tyrosine kinases, the finding that in several cases, perhaps best illustrated by the T-cell receptor complex [31] , many sites with similar sequence contexts are present on the same substrate molecule suggests a functional role in vivo for the type of processive phosphorylation described here. Furthermore, Wang's group has reported [32] that c-Abl can phosphorylate the carboxy-terminal domain of RNA polymerase II to very high stoichiometry. We suggest that processive phosphorylation is biologically important, providing a means by which to generate coordinate 'all-or-nothing' phosphorylation of many sites on a substrate protein even at low concentrations of both substrate and kinase. Certainly, the observation that the Abl kinase requires an SH2 domain in order to be able to transform cells [17] suggests that processive phosphorylation of proteins might have profound physiological consequences.
It is of particular interest that substrate specificity can be altered by the binding of heterologous SH2 domains in separate molecules (in trans). This would allow a single kinase to be directed to different substrates, depending on the local availability of 'processivity factors' such as Crk. Proteins other than Crk are also likely to function in such a role. For example, the Grb2 adaptor binds to the Abl carboxyl terminus [18, 19] and can facilitate processive phosphorylation (data not shown); another SH2-containing protein, 3BP2, has also been shown to bind to the Abl SH3 domain [33] [34] [35] . Abl may actually be associated in vivo with a number of different 'prosthetic' SH2 domains, allowing it to target a wide range of potential substrates. Our results also suggest a straightforward and rational way to redirect the substrate specificities of the non-receptor kinases by appending selected SH2 domains in cis or in trans.
The binding of Crk to Abl raises the possibility that Crk binding may be important for the biological activity of Abl, or conversely that Abl binding may be critical for transformation by Crk. Although not required for the transformation of fibroblasts, the carboxyl terminus of Abl is required for the transformation of lymphoid cells [36] , suggesting that Crk binding could b-eimportant for targeting lymphoid-specific substrates. Although it is not yet known whether p130 is a natural target of Abl in vivo, transfection of 293 cells with Abl greatly increases tyrosine phosphorylation of GST-p130, and this depends on the presence of an intact SH2 domain in Abl (data not shown).
It is likely that endogenous c-Abl is at least partly responsible for the increase in tyrosine phosphorylation of cellular proteins (including p 1 30) that is seen in cells transformed by overexpression of Crk, given that the Abl-Crk complex has been shown to exist in vivo [18, 19] , and we show here that the complex can very efficiently phosphorylate p1 30 in vitro. A role for Abl in transformation by Crk is also suggested by the correlation between the transforming activity of Crk mutants and their ability to promote p1 30 hyperphosphorylation by Abl. Consistent with this, co-transfection of c-Abl with Crk-1 or Crk-2 induces hyperphosphorylation of GST-pl30 in 293 cells, as compared to parallel transfections lacking either Crk or Abl; in addition, co-transfection of Crk can rescue the inability of Abl mutants lacking an SH2 domain to phosphorylate GST-pl130 (our unpublished observations).
Finally, these results suggest a novel role for the SH2-SH3 adaptor proteins: they may act as processivity factors for Abl and perhaps other kinases. Current models of adaptor protein function are based on the Grb2/Sem5 paradigm, SH2 domains and processive phosphorylation Mayer et al. derived largely from genetic studies in Caenhorabditis elegans and Drosophila melanogaster [37] [38] [39] . These studies, together with biochemical analyses, suggested that Grb2 serves to couple membrane events to downstream effectors, specifically by binding to autophosphorylated growth factor receptors through its SH2 domain and to the Ras activator, Sos, through its SH3 domains [20] . Our studies suggest that we should consider a more general role for the adaptors in modulating the binding activity of proteins with which they associate.
Conclusion
SH2 domains are found in most non-receptor tyrosine kinases. We propose that the SH2 domain functions in these kinases to facilitate the processive phosphorylation of substrate proteins that have multiple potential phosphorylation sites. Our model is outlined in Figure 6 . Once the catalytic domain has phosphorylated a site on a substrate protein, there are two possible outcomes. If the tyrosine-phosphorylated site cannot bind an SH2 domain on the kinase, either because the site has low affinity for the SH2 domain or because the SH2 domain has been deleted or mutated, then the substrate will be released. Because of the high levels of tyrosine phosphatase activity in normal cells, the substrate is likely to be rapidly dephosphorylated. If, on the other hand, the phosphorylated site can bind with high affinity to a kinase-associated SH2 domain, many other sites on the substrate will be subsequently phosphorylated as a result of their proximity to the catalytic domain. Although most non-receptor tyrosine kinases contain an SH2 domain in cis (within the same molecule as the catalytic domain), we have shown that the Abl kinase can also acquire an additional SH2 -that of the Crk adaptor protein -in trans. The bound adaptor serves as a processivity factor, by broadening the range of phosphorylated sites that can tightly bind to the kinase, and serves to initiate processive phosphorylation. This proposed mechanism is likely to be involved in the normal function of the non-receptor kinases, and in their abnormal function in cells malignantly transformed by mutant kinases or by the crk oncogene.
Materials and methods
DNA constructs
The construction of baculovirus vectors expressing the murine type IV c-abl product fused to GST, and various mutants derived from the wild-type c-abl, has been described previously [17] . The.mutants termed E, F and G in our previous publication [17] are termed ASH2, c-Abl and ASH3, respectively, in this study. For expression of GST-Abl fusion proteins in mammalian cells by transient transfection, the vector pEBG was used; pEBG is derived from pEF-BOS, an expression vector driven by the human elongation factor 1-ao promoter [40] . The BstXI-NotI stuffer fragment of pEF-BOS was replaced with a polylinker containing a BamHI site. The polymerase chain reaction (PCR) was used to generate a fragment containing the GST-coding region of pGEX-2T [41] , with a 5' BglI site and eukaryotic ribosome binding site and the 3' BamHI site of pGEX-2T, which was then inserted into the BamHI site to generate pEBG. Coding regions of various abl mutants were cloned into the BamHI and Notd sites of pEBG as described previously for the baculovirus expression vectors [17] , resulting in the BamHI site of GST being followed in-frame by the codon for the position 2 glycine of Abl.
The coding region for the short form of rat p1 3 0CAS [26] was also cloned into pEBG. PCR was used to synthesize a DNA fragment corresponding to the entire coding region of p130. The 5' primer contained a BamHI site followed by the nucleotides GGCACC (encoding glycine and threonine) followed by the initiation codon and 16 additional homologous nucleotides. The 3' primer was homologous to nucleotides 2932-2955 of the published sequence, which contain the termination codon, and included a terminal Notd site. The fragment was amplified using fu DNA polymerase (Stratagene) to reduce polymerase errors, digested with BamHI and NotI, and cloned into pEBG. Two independent PCR clones were characterized; both behaved identically, and their termini had the expected DNA sequence.
The GST-Crk fusion proteins will be described more fully elsewhere. Briefly, PCR was used to amplify full-length chicken c-crk cDNA (Crk-2) [28] , or a fragment of the chicken gene corresponding to the human Crk-1 form. Amplified fragments containing 5' BamHI and 3' Notd sites were cloned into a modified form of pGEX-2T (termed pGEX-2N) containing a Notl site 3' to the BamHI site. Mutants with single aminoacid changes in the SH3, SH2 or tyrosine phosphorylation sites were generated by PCR using mutant oligonucleotides. Mutant Crk-1K17O is a Crk-1 protein with lysine instead of tryptophan at position 170 (which corresponds to the invariant tryptophan found in all SH3 domains). Mutant Crk-2K 38 is a Crk-2 protein with lysine instead of arginine at position 38 (corresponding to the invariant arginine in the phosphatebinding site of all SH2 domains). Crk-2F 22 2 is a Crk-2 protein with a phenylalanine instead of tyrosine 222, the major site of tyrosine phosphorylation [181.
Protein production and purification
The purification of recombinant GST-Abl proteins from baculovirus-infected Sf9 insect cells and cleavage from GST with thrombin has been described previously [17] . For some experinments (Fig. 4, Fig. 5 and Table 1 ), the purified Abl proteins were dephosphorylated with recombinant tyrosine phosphatase produced in E. coli, because c-Abl protein is not normally phosphorylated on tyrosine in vivo [42, 43] , but when produced in insect cells it has significant tyrosine phosphorylation ( [42] and data not shown). A plasmid encoding GST-PTP-1B [44] was kindly provided by B. Neel. Bacteria expressing the phosphatase were inoculated 1:20 from overnight cultures into prewarmed LB medium, grown for 2 h at 37 °C, then induced with 0.1 mM IPTG. After growing for 3 h, cells were harvested and lysed by sonication in 0.1 culture volume of PLB buffer (20 mM Tris, pH 7.4, 150 mM NaCI, 10 mM Na 2 EDTA, 10 mM DTT, 10 % glycerol, 1 % Triton X-100, 1 mM PMSF, 20 ,ug ml -1 aprotinin). Lysates were cleared at 16 000 x g for 5 min and GST-PTP-1B was bound to glutathione-agarose beads (Molecular Probes). Beads were washed four times with PRB buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 2 mM Na 2 EDTA, 2 mM DTT, 10% glycerol, 0.1 % Triton X-100, 1 mM PMSF, 20 pLg ml-' aprotinin), then purified, thrombin-cleaved Abl protein was added to beads in PRB and incubated with' rotation at room temperature for 30 min. The supernatant was then passed over a column with immobilized phosphotyrosine-specific monoclonal antibody PY20 [45] to remove residual tyrosine-phosphorylated protein. The resulting Abl protein contained no detectable phosphotyrosine by immunoblotting with anti-phosphotyrosine antibodies.
GST-p130 and the GST-Abl variants used in the experiment shown Figure 3 were produced by transient transfection of 293 cells with EBG-derived plasmids. Cells were transfected with 4 Rg of plasmid DNA per 10 cm dish by calcium phosphate co-precipitation, essentially as described [46] . Cells were harvested 2 days post-transfection in 1 ml TXB buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 5 mM Na 2 EDTA, 10 % glycerol, 1 % Triton X-100, 1 mM DTT, 1 mM PMSF, 20 pg ml-1 aprotinin), and lysates were cleared by centrifugation and incubated with glutathione-agarose beads at 4 C. Beads were washed with TNGT buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 10 % glycerol, 0.1 % Triton X-100) and eluted in a small volume of TNGT supplemented with 20 mM reduced glutathione (pH 7.4) and 1 mM DTT. Acetylated BSA was added to reach a final concentration of 0.1 mg ml-' and purified proteins were stored at -70 °C. GST-Crk fusion proteins were produced in E. coli and purified as described [41] . Proteins were quantitated by Bradford assay (BioRad) using human y-globulin as a standard, and stored in PBS containing 10 % glycerol.
Kinase assays
Kinase reactions were performed in a buffer containing 50 mM Hepes, pH 7.4, 10 mM MgCI 2 , 0.1 mg ml-' acetylated BSA, 100 p.M ATP and 5-10 p.Ci per reaction [y- 32 P]ATP at 30 °C for 5-10 min. GST-p130 substrate was used at an estimated final concentration of 10-25 g ml- 1 ; poly(Glu-Tyr) (4:1; Sigma P-0275) was used at 0.5 mg ml-1; and (Val 5 )angiotensin II (Sigma A-2900) was used at 1 mg ml-'. In experiments using dephosphorylated Abl proteins, 1 mM Na 3 VO 4 was included to inhibit any contaminating phosphatase. For analysis of reaction products by gel electrophoresis, 20 p.
1 reactions were terminated by adding 5 p.
1 five-fold concentrated Laemmli sample buffer, boiled for 3 min, and separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on 8.5 % or 12 % polyacrylamide gels. Gels were fixed for 3 x 20 min in 10 % acetic acid, 10 % methanol (a trace of Coomassie brilliant blue was present in the first fix to stain proteins), dried and exposed for autoradiography at room temperature. Radioactive phosphate incorporated into angiotensin was quantitated by phosphocellulose paper binding as previously described [17] . Radioactive phosphate incorporated into poly(Glu-Tyr) was quantified by cutting gel bands and 'Cerenkov counting in a liquid scintillation counter. Within an experiment, the different Ablderived kinases were normalized for equal activity toward poly(Glu-Tyr) or (Val 5 )angiotensin II. In all cases, Abl concentrations were low relative to those of p130 substrate, but were not precisely calculated; in the experiments shown in Figure 1 , -25 ng purified kinase was used per reaction, whereas in the experiments shown in Figures 4 and 5 , -2.5 ng was used.
For experiments involving Crk binding, purified GST-Crk proteins were added to purified, dephosphorylated Abl along with p130 substrate in a total volume of 8 p.l, and incubated on ice for 20 min; we then added a cocktail containing reaction buffer components (12 p.l total) and incubated at 30 °C for 5 min. For the experiment shown in Figure 4 , initial (binding) and final (reaction) GST-Crk concentrations were approximately 5 and 2 F.M, respectively. For the experiment shown in Figure 5 , the highest GST-Crk concentration (lane 1) was the same as in Figure 4 and was decreased serially three-fold (giving initial and reaction concentrations of approximately 20 and 8 nM, respectively, for the lowest concentration shown, in lane 6).
